sch 16134 has been researched along with Chronic Disease in 3 studies
quazepam: structure given in first source
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tietz, EI | 1 |
| Roth, T | 1 |
| Zorick, FJ | 1 |
| Piccione, P | 1 |
| Kramer, M | 1 |
| Walsh, JK | 1 |
| Mahowald, MW | 1 |
| Mamelak, M | 1 |
| Csima, A | 1 |
| Price, V | 1 |
1 trial available for sch 16134 and Chronic Disease
| Article | Year |
|---|---|
The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; | 1981 |
2 other studies available for sch 16134 and Chronic Disease
| Article | Year |
|---|---|
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepa | 1991 |
Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Drug Tolerance; Female; Humans; Male; | 1985 |